PAVmed Inc Warrants (PAVMW)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Lishan Aklog
Employees:
90
ONE GRAND CENTRAL PLACE, SUITE 4600, NEW YORK, NY 10165
212-949-4319

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE)

Data derived from most recent annual or quarterly report
Market Cap 305.472 Thousand Shares Outstanding10.534 Million Avg 30-day Volume 10.217 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.16
Price to Revenue53.1923 Debt to Equity-51.7952 EBITDA-84.123 Million
Price to Book Value0.0 Operating Margin-10586.625 Enterprise Value81.904 Million
Current Ratio0.849 EPS Growth0.034 Quick Ratio0.733
1 Yr BETA 2.2318 52-week High/Low 4.74 / 0.02 Profit Margin-11826.25
Operating Cash Flow Growth-9.4287 Free Cash Flow to Firm (FCFF) TTM -58.531 Million Free Cash Flow to Equity (FCFE) TTM-39.713 Million
Altman Z-Score-11.8383
View SEC Filings from PAVMW instead.

View recent insider trading info

PAVmed Inc Warrants YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding PAVMW (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PAVMW

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-06-09 by GORDON MICHAEL ADAM
  • 3: filed on 2022-06-08 by GORDON MICHAEL ADAM
  • 4: filed on 2020-05-04 by WEILD IV DAVID
  • 4: filed on 2020-05-04 by SPARKS RONALD M
  • 4: filed on 2020-05-04 by GLENNON MICHAEL J
  • 4: filed on 2020-05-04 by DEGUZMAN BRIAN J.
  • 4: filed on 2020-05-04 by COX JAMES L
  • 4: filed on 2020-05-04 by BATTLEMAN DAVID S.
  • 4: filed on 2020-05-04 by MCGRATH DENNIS M
  • 4: filed on 2019-03-12 by COX JAMES L

    • Events (8k)

  • 8-K: filed on 2023-11-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-18:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-28:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-21:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-06:
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-03:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-31:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-24:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-14:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GORDON MICHAEL ADAM GENERAL COUNSEL

    • Officer
    		 400,000 2022-06-07 0

    MCGRATH DENNIS M PRESIDENT & CFO

    • Officer
    		 791,704 2020-04-30 0

    WEILD IV DAVID

    • Director
    		 0 2020-04-30 0

    DEGUZMAN BRIAN J. CHIEF MEDICAL OFFICER

    • Officer
    		 0 2020-04-30 0

    SPARKS RONALD M

    • Director
    		 0 2020-04-30 0

    GLENNON MICHAEL J VICE CHAIRMAN

    • Officer
    • Director
    		 0 2020-04-30 0

    COX JAMES L

    • Director
    		 0 2020-04-30 0

    BATTLEMAN DAVID S.

    • Director
    		 0 2020-04-30 0

    SIROVICH MATTHEW

    • 10% Owner
    		 4,145,201 2020-01-30 0

    AKLOG LISHAN CHAIRMAN AND CEO

    PAVILION VENTURE PARTNERS LLC

    • Officer
    • Director
    • 10% Owner
    		 5,299,566 2019-03-15 0

    GREENSPAN IRA SCOTT

    • 10% Owner
    		 421,691 2018-06-08 0

    AKLOG LISHAN CHAIRMAN AND CEO

    HCFP/CAPITAL PARTNERS III LLC

    PAVILION VENTURE PARTNERS LLC

    • Officer
    • Director
    • 10% Owner
    		 0 2018-04-05 0

    LAMSTEIN JOSHUA R

    • Director
    		 163,377 2017-12-21 0

    FITZGERALD RICHARD F CFO AND SECRETARY

    • Officer
    		 0 2016-04-28 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments